Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 442 of 6351
-
Can mirikizumab mend the gut? new trial aims for deep healing in Crohn's
Disease control Recruiting nowEfficacy of Mirikizumab to achieve transmural healing in patients with Crohn's Disease
Phase 4 • Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New hope: drug may prevent dangerous reactions to cancer immunotherapy
Disease control Not yet recruitingThe purpose of this study is to evaluate emapalumab as a prophylactic therapy in preventing cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) in patients with hematologic malignancies receiving bispecific antibodies (BsAbs) as outp…
Phase 2 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug combo shows promise in shrinking head and neck tumors before surgery
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the anti-tumor activity, safety and tolerability of the combination of Sacituzumab govitecan and Tagitanlimab as neoadjuvant therapy in patients with resectable head and neck squamous cell carcinoma (HNSCC). It will also explore pote…
Phase 2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Precision radiation takes on liver cancer: could SABR beat standard care?
Disease control Recruiting nowThis Phase II Prospective, parallel and open-label randomised control trial will investigate whether a radiotherapy technique (called SABR) can treat early stage liver cancer more effectively than current treatments which use heating probes directly inserted into the tumour or ch…
Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Blood pressure check without the squeeze: a camera might do it
Diagnosis Recruiting nowThe purpose of this clinical investigation is to collect data for the development, testing, and validation of a blood pressure measurement algorithm for a contactless vital signs monitor, Vitacam, according to the ISO 80601-2:2019 standard for validating non-invasive sphygmomanom…
Sponsor: Evondos Oy • Aim: Diagnosis
Last updated Aug 02, 2026 00:00 UTC
-
Can reflex exercises unlock better hand skills in kids with delays?
Disease control CompletedDevelopmental delay refers to a child's failure to achieve age-appropriate developmental milestones and may affect multiple developmental domains. MNRI (Masgutova Neurosensorimotor Reflex Integration) therapy is designed to improve sensory-motor integration, motor coordination, a…
Sponsor: Riphah International University • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a lawyer reduce gun violence? trial adds legal aid to trauma recovery
Disease control Recruiting nowHospital-Based Violence Intervention Programs (HVIPs) affiliated with U.S. trauma centers often focus on individual behavior modification to reduce re-victimization. There is a lack of reproducible evidence that has demonstrated effectiveness, given the exclusion of addressing so…
Sponsor: University of Chicago • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New hope for stomach and bowel cancers: experimental drug Rina-S enters Mid-Stage trial
Disease control Recruiting nowThis Phase 2 study will be conducted in different countries around the world with up to about 160 participants. The purpose of this study is to evaluate how well Rina-S works against GI cancers. The medication in this study is Rina-S monotherapy (by itself; no other cancer trea…
Phase 2 • Sponsor: Genmab • Aim: Disease control
Last updated Sep 10, 2026 04:00 UTC
-
New pill could cut heart failure deaths when given early in hospital
Disease control Recruiting nowFACILITATE-HF is a multicenter, randomized, double-blind, placebo-controlled trial designed to determine whether initiation of finerenone during the early phase of hospitalization has beneficial effects in patients with AHF who have left ventricular ejection fraction 40% or more.
Phase 4 • Sponsor: Juntendo University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New obesity drug aims to help keep weight off after switching from popular injections
Disease control Recruiting nowEfficacy, safety and tolerability of switching from GLP-1RA to maridebart cafraglutide in adults with obesity or overweight.
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New monthly shot could keep severe asthma patients out of the ER
Disease control Recruiting nowAdults with severe asthma may have sudden worsening shortness of breath that results in their going to Emergency Department for urgent care. Emergency Room visits for asthma management across Alberta have been reviewed and it has been found that adults frequently need to return f…
Phase 4 • Sponsor: University of Alberta • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New shot aims to cut heart failure deaths in obese patients
Disease control Recruiting nowThis study is being done to look at the safety and effect of NNC0487-0111 in people with Heart Failure with preserved Ejection Fraction (HFpEF) or Heart Failure with mildly reduced Ejection Fraction (HFmrEF) and excess body weight when compared to placebo. The purpose of this cli…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Could a common mineral salt boost survival after pesticide poisoning?
Disease control Recruiting nowPakistan, being a developing country, is one of the regions with the most cases of organophosphate (OP) poisoning/toxicity. MgSO4 is one of the most promising adjunctive treatments that needs to be tested. This study is being carried out with the objective of comparing the 15-day…
Sponsor: Muhammad Aamir Latif • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New CAR T-Cell therapy targets Hard-to-Treat multiple myeloma in early trial
Disease control Not yet recruitingThis study is a single-armed, open-label, multicenter Phase 1/2 study to evaluate the efficacy and safety of Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (Equecabtagene Autoleucel) in subjects with relapsed and refractory Multiple Myeloma.
Phase 1/2 • Sponsor: Nanjing IASO Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug cocktail aims to shrink inoperable lung tumors enough for surgery
Disease control Not yet recruitingThis study is a phase 2 open-label, single-center clinical study to evaluate the efficacy and safety SKB264 in combination with toripalimab in patients with unresectable stage III non-small cell lung cancer
Phase 2 • Sponsor: Hunan Province Tumor Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug combo aims to shrink lung tumors before surgery
Disease control Not yet recruitingThis is a single-center, single-arm, phase 2 trial evaluating the efficacy and safety of retlirafusp alfa combined with single-agent chemotherapy as neoadjuvant treatment for patients with resectable stage II-III EGFR/ALK wild-type non-small cell lung cancer (NSCLC).Eligible pati…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a short talk therapy cut suicide risk? brazil launches major trial
Symptom relief Not yet recruitingThe vast majority of suicides occur in low-and middle-income countries (LMICs), and evidence on effective psychotherapeutic interventions to prevent suicide that are culturally adapted to these contexts is limited. This scenario implies an urgent need for evidence-based suicide p…
Phase 3 • Sponsor: University of Sao Paulo • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Could a Psychedelic-Like pill beat depression? phase 3 trial underway
Symptom relief Recruiting nowA Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Major Depressive Disorder - Ascend
Phase 3 • Sponsor: Definium Therapeutics US, Inc. • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
New hope for Early-Relapse colorectal cancer: immune booster added to chemo
Disease control Recruiting nowApproximately 20-50% of patients with colorectal cancer (CRC) develop distant metastasis after curative surgery, and those with early relapse within one year of completing adjuvant chemotherapy (XELOX or FOLFOX) have a particularly poor prognosis and limited treatment options. St…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New blood filter could save lives in sudden liver failure
Disease control Not yet recruitingAcute-on-chronic liver failure (ACLF) is a serious condition in which patients with chronic liver disease suddenly develop severe liver injury, leading to inflammation, organ failure, and very high short-term mortality. Standard medical treatment can help, but many patients still…
Sponsor: Institute of Liver and Biliary Sciences, India • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC